Patents by Inventor Vishwaraman Mohan
Vishwaraman Mohan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20130089605Abstract: Disclosed is a commercially viable asiaticoside composition having at least 99% purity that is derived from plant Centella asiatica and a manufacturing process thereof. Also disclosed is a method and the models for oral administration of therapeutically effective amounts of the asiaticoside composition for treatment of Inflammatory Bowel Diseases such as Ulcerative colitis, Crohn's disease and associated complications of inflammatory bowel diseases such as hemorrhoids, anal fissures, fistulas. Also disclosed is a method and model for oral administration of therapeutically effective amounts of the asiaticoside composition for treatment of Helicobacter Pylori, as well as a method and the models for oral administration of therapeutically effective amounts of the asiaticoside composition for prevention of colon cancer, gastric diseases and gastric carcinoma.Type: ApplicationFiled: August 31, 2010Publication date: April 11, 2013Applicant: INDUS BIOTECH PRIVATE LIMITEDInventors: Bhaskaran Sunil, Vishwaraman Mohan
-
Patent number: 7736676Abstract: A synergistic composition for the treatment of diabetes in a subject in need thereof, said composition-comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: GrantFiled: July 11, 2006Date of Patent: June 15, 2010Assignee: Indus Biotech Pvt. Ltd.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Patent number: 7674485Abstract: A composition for the treatment of diabetes in a subject in need thereof, said composition—comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: GrantFiled: February 15, 2006Date of Patent: March 9, 2010Assignee: Indus Biotech Pvt. Ltd.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Patent number: 7641925Abstract: A synergistic composition for the treatment of diabetes in a subject in need thereof, comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: GrantFiled: February 15, 2006Date of Patent: January 5, 2010Assignee: Indus Biotech Pvt. Ltd.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Publication number: 20080199517Abstract: The present invention relates to a novel herbal composition for improving exercise physiology factors comprising saponins and sugar derivatives optionally along with pharmaceutically acceptable excipients. It also relates to the process of preparing the composition for improving exercise physiology factors comprising the steps of flaking, defatting, solvent extraction of seeds of trigonella species followed by concentration of the extract to obtain a saponin and sugar derivative. It also relates to the use of the composition for improving exercise physiology factors comprising, enhanced anabolic activity, enhanced muscle building, enhance creatine delivery and reuptake, an increase in testosterone levels and an enhanced immunity.Type: ApplicationFiled: February 15, 2008Publication date: August 21, 2008Applicant: INDUS BIOTECH PRIVATE LTDInventors: Bhaskaran Sunil, Vishwaraman Mohan
-
Publication number: 20070219146Abstract: The present invention relates to a synergistic pharmaceutical and/or neutraceutical flavanoid composition for management of Diabetes Mellitus, said composition comprising polyphenol of concentration ranging between 85 to 95% (w/w) GAE, theobromine of concentration ranging between 1 to 5% (w/w), and moisture content ranging between 0.5 to 10% (v/w).Type: ApplicationFiled: January 31, 2007Publication date: September 20, 2007Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Patent number: 7179930Abstract: The present invention relates to a process for obtaining stabilized Lutein with about 95% yield from oleoresin at ambient temperature, said process comprising steps of dissolving cleaned oleoresin in alcohol to obtain dissolved Xanthophylls esters as clear solution on filtration, cleaning dissolved oleoresin comprising xanthophylls esters in ion-exchange resin, hydrolyzing the clear solution with base in presence of phase-transfer catalyst in alcohol medium, quenching the hydrolyzed solution in water maintaining acidic pH to obtain undissolved solids on filtration, dissolving the solids in ester to obtain ester layer on filtration, drying ester layer to obtain semi-solid residue, triturating the semi-solid residue in alcohol whereby obtaining lutein crystals of about 65% assay and an alcoholic fraction, distilling the alcoholic fraction to obtain non water-soluble fractions, and mixing the Lutein crystals with non water-soluble fractions to obtain a stable Lutein paste.Type: GrantFiled: January 18, 2005Date of Patent: February 20, 2007Assignee: Indus Biotech Private LimitedInventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Publication number: 20070031521Abstract: The present invention relates to a synergistic composition for the treatment of diabetes in a subject in need thereof, said composition-comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: ApplicationFiled: July 11, 2006Publication date: February 8, 2007Applicant: Indus Biotech Pvt. Ltd.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Publication number: 20060292252Abstract: The present invention relates to a synergistic composition for the treatment of diabetes in a subject in need thereof, said composition-comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: ApplicationFiled: June 6, 2006Publication date: December 28, 2006Applicant: Indus Biotech Pvt. Ltd.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Patent number: 7141254Abstract: The present invention relates to a synergistic composition for the treatment of diabetes in a subject in need thereof, said composition-comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: GrantFiled: May 14, 2004Date of Patent: November 28, 2006Assignee: Indus Biotech Pvt. Ltd.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Publication number: 20060153937Abstract: The present invention relates to a synergistic composition for the treatment of diabetes in a subject in need thereof, said composition-comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: ApplicationFiled: February 15, 2006Publication date: July 13, 2006Applicant: INDUS BIOTECH PVT. LTD.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Publication number: 20060134242Abstract: The present invention relates to a synergistic composition for the treatment of diabetes in a subject in need thereof, said composition—comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: ApplicationFiled: February 15, 2006Publication date: June 22, 2006Applicant: INDUS BIOTECH PVT. LTD.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Publication number: 20050182280Abstract: The present invention relates to a process for obtaining stabilized Lutein with about 95% yield from oleoresin at ambient temperature, said process comprising steps of dissolving cleaned oleoresin in alcohol to obtain dissolved Xanthophylls esters as clear solution on filtration, cleaning dissolved oleoresin comprising xanthophylls esters in ion-exchange resin, hydrolyzing the clear solution with base in presence of phase-transfer catalyst in alcohol medium, quenching the hydrolyzed solution in water maintaining acidic pH to obtain undissolved solids on filtration, dissolving the solids in ester to obtain ester layer on filtration, drying ester layer to obtain semi-solid residue, triturating the semi-solid residue in alcohol whereby obtaining lutein crystals of about 65% assay and an alcoholic fraction, distilling the alcoholic fraction to obtain non water-soluble fractions, and mixing the Lutein crystals with non water-soluble fractions to obtain a stable Lutein paste.Type: ApplicationFiled: January 18, 2005Publication date: August 18, 2005Applicant: INDUS BIOTECH PVT. LTD.Inventors: Sunil Bhaskaran, Vishwaraman Mohan
-
Publication number: 20050008716Abstract: The present invention relates to a synergistic composition for the treatment of diabetes in a subject in need thereof, said composition-comprising Trigonelline of concentration ranging between 20 to 30%, amino acids of concentration ranging between 20 to 60%, and soluble fiber of concentration ranging between 10 to 60%, optionally along with pharmaceutically acceptable additives, a process thereof and also, a method of treating diabetes.Type: ApplicationFiled: May 14, 2004Publication date: January 13, 2005Applicant: INDUS BIOTECH PVT. LTD.Inventors: Sunil Bhaskaran, Vishwaraman Mohan